-
Published 2/5/2026
Peoples AR, Obón-Santacana M, Kim AE, Kawaguchi ES, Fu Y, Qu C, Moratalla-Navarro F, Morrison J, Lin Y, Arndt V, Berndt SI, Bien SA, Bishop DT, Bouras E, Brenner H, Buchanan DD, Campbell PT, Chan AT, Chang-Claude J, Conti DV, Corley DA, Devall MA, Dimou N, Drew DA, Gruber SB, Gunter MJ, Harlid S, Harrison TA, Hoffmeister M, Hsu L, Huyghe JR, Keku TO, Kundaje A, Lewinger JP, Li L, Lynch BM, Le Marchand L, Martín V, Murphy N, Newton CC, Ogino S, Hardikar S, Ose J, Pai RK, Palmer JR, Papadimitriou N, Pardamean B, Pellatt AJ, Pinchev M, Platz EA, Potter JD, Rennert G, Ruiz-Narvaez EA, Sakoda LC, Schoen RE, Shcherbina A, Stern MC, Su YR, Thomas CE, Tian Y, Tsilidis KK, Um CY, van Duijnhoven FJB, Van Guelpen B, Visvanathan K, Wang J, White E, Wolk A, Woods MO, Wu AH, Ulrich CM, Peters U, Gauderman WJ, Moreno V. Genetic risk factors modulate the association between physical activity and colorectal cancer. BMC Med. 2026 Feb 05; 24(1). PMID: 41645200.
-
Published 1/27/2026
Mitra PR, Bertrand KA, Pfeiffer RM, Palmer JR, Ramireddy S, Hyer M, Fan S, Strohsnitter WC, Aagaard KM, Huo D, Titus L, Troisi R, Gierach GL. Prenatal diethylstilbestrol exposure and risk of benign breast disease: The National Cancer Institute Diethylstilbestrol Follow-up Study. Int J Cancer. 2026 Jun 15; 158(12):3101-3111. PMID: 41590827.
-
Published 12/1/2025
O'Brien KM, Keil AP, Taylor JA, Weinberg CR, Polley EC, Yadav S, Boddicker NJ, Hu C, Ambrosone CB, Anton-Culver H, Auer PL, Bodelon C, Brantley K, Burnside ES, Chen F, Domchek SM, Eliassen AH, Haiman CA, Hodge JM, Kraft P, Lacey JV, Lindstroem S, Martinez ME, Nathanson KL, Neuhausen SL, Olson JE, Palmer JR, Patel AV, Penney KL, Ruddy KJ, Scott CG, Teras LR, Trentham-Dietz A, Vachon CM, Weitzel JN, Yao S, Zirpoli G, Couch FJ, Sandler DP. Pathogenic Variants, Family History, and Cumulative Risk of Breast Cancer in US Women. JAMA Oncol. 2025 Dec 01; 11(12):1458-1469. PMID: 41066089.
-
Published 11/25/2025
Xu NN, Barnard ME, Holder EX, Rosenberg L, Ko N, Palmer JR. Perceived racial discrimination in health care in relation to late stage at breast cancer diagnosis. Breast Cancer Res. 2025 Nov 25; 27(1):208. PMID: 41291827.
-
Published 10/30/2025
Billaud A, Figlioli G, Mooser C, Casamassima I, Azzoni V, Srivatsa J, Colombo M, Caleca L, Ahearn TU, Andrulis IL, Antoniou AC, Beckmann MW, Behrens S, Bermisheva M, Bogdanova NV, Bolla MK, Bonanni B, Brüning T, Camp NJ, Campbell A, Castelao JE, Cessna MH, Chang-Claude J, Czene K, Dennis J, Devilee P, Dörk T, Dunning AM, Eriksson M, Evans DG, Fasching PA, Figueroa JD, Gabrielson M, Gago-Dominguez M, González-Neira A, Guénel P, Hadjisavvas A, Hahnen E, Hamann U, Hillemanns P, Hollestelle A, Hooning MJ, Hoppe R, Howell A, Jakubowska A, Kristensen VN, Lubinski J, Lush M, Manoukian S, Mavroudis D, Milne RL, Mulligan AM, Newman WG, Obi N, Panayiotidis MI, Pita G, Rashid MU, Rhenius V, Saloustros E, Sawyer EJ, Schmutzler RK, Shah M, Southey MC, Spurdle AB, Tomlinson I, Truong T, Wang Q, Wendt C, Auer PL, Boddicker NJ, Bodelon C, Burnside ES, Chen F, Couch FJ, Domchek SM, Eliassen HA, Haiman C, Hodge JM, Hu C, Huang H, Lindstrom S, Martinez ME, Nathanson KL, Neuhausen SL, O'Brien KM, Olson JE, Palmer JR, Patel AV, Ruddy KJ, Sandler DP, Teras LR, Weinberg CR, Weitzel JN, Winham SJ, Yadav S, Yao S, Zirpoli G, Janatova M, Kleibl Z, Kleiblova P, Soukupova J, Zhao Q, Devereux L, James PA, Campbell IG, Nguyen-Dumont T, Dowty JG, Andrieu N, Lesueur F, Stoppa-Lyonnet D, Hoya M, Radice P, Sørensen CS, Peterlongo P. Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer. Breast. 2026 Feb; 85:104619. PMID: 41223770.